EntroGen News & Events
EntroGen announces CE-IVD marking of its BRCA Complete™ BRCA1/BRCA2 sequencing kit
Today EntroGen Inc. announced CE-IVD marking of its BRCA Complete™ kit, a targeted next generation sequencing (NGS) panel for BRCA1 and BRCA2 exome sequencing on Illumina® MiniSeq, MiSeq, and NextSeq platforms.
EntroGen announces CE-IVD marking of its comprehensive Colorectal Cancer DNA panel and Thyroid Cancer kits
Today EntroGen Inc. announced CE-IVD marking of its Colorectal Cancer Panel (CRC), Thyroid Cancer Mutation Analysis kit (THDNA), and Thyroid Cancer Fusion Gene Detection kit (THRNA).
EntroGen releases BRCA Complete™ for targeted BRCA1/BRCA2 sequencing
Today EntroGen, Inc. has launched BRCA Complete™: a targeted next generation sequencing (NGS) panel for BRCA1 and BRCA2 exome sequencing on Illumina® MiniSeq, MiSeq, and NextSeq platforms.
EntroGen Launches Multiplexed Leukemia Translocation Panel
Today EntroGen (http://www.entrogen.com) announced immediate availability of its new Leukemia Translocation Panel—a multiplexed, one-step RT-PCR assay that detects eleven variants in 6 common leukemia-associated translocations simultaneously.
EntroGen announces immediate availability of its comprehensive Colorectal Cancer Mutation Detection Panel
October 3, 2016
EntroGen Newsletter
Receive quarterly updates on EntroGen news and products.